U.S. Telecom Services and Carriers Stock News

GPGI (GPGI) is drawing fresh attention after first quarter 2026 results combined record sales at CompoSecure with a US$235 million net loss and weaker Husky performance, along with a new international commercial leadership appointment. See our latest analysis for GPGI. The first quarter loss and Husky headwinds have coincided with sharp share price weakness, with a 1 day share price return of negative 25.9% and a 90 day share price return of negative 47.1%. However, the 3 year total...

If you are wondering whether DENTSPLY SIRONA stock is starting to look interesting at current levels, its recent price and valuation signals give you a lot to think about. The share price sits at US$10.96 after a 6.7% decline over the last week, a 4.9% decline over the last month and a 28.5% decline over the last year, which may change how you view both its risk and potential reward. Recent coverage around DENTSPLY SIRONA has focused on its position within the medical equipment space and how...

Repligen (RGEN) is back in focus after its first quarter 2026 earnings, where profit topped market expectations, full year adjusted earnings guidance moved higher, and the stock gained 7.3% on the news. See our latest analysis for Repligen. Beyond the post earnings jump, Repligen’s 7 day share price return of 6.86% and 30 day share price return of 9.66% sit against a year to date share price decline of 23.07%. The 1 year total shareholder return of a 1.11% decline and 3 year total shareholder...

What Crane’s latest earnings and M&A comments mean for investors Crane (CR) just paired a Q1 earnings beat with a slight uptick in full year adjusted EPS guidance, yet a softer operating margin and active acquisition agenda are shaping how investors reassess the stock. See our latest analysis for Crane. Crane’s recent Q1 earnings beat, slight full year EPS guidance increase, dividend affirmation, and active M&A commentary come after a 1 year total shareholder return of 7.6%. The 3 year total...

In early May 2026, Clean Harbors, Inc. reported first-quarter 2026 results showing revenue of US$1,459.54 million and net income of US$63.2 million, and issued full-year 2026 GAAP net income guidance of US$421 million to US$472 million. The quarter also featured record safety performance, strong landfill volume growth tied to PFAS and project work, and higher full-year adjusted EBITDA guidance supported by operational efficiency initiatives, including AI deployment and new field service...

In the first quarter of 2026, First Solar reported sales of US$1,044.24 million and net income of US$346.62 million, with basic earnings per share from continuing operations of US$3.23, all higher than a year earlier. Alongside these results, the company reaffirmed its 2026 outlook, including expected module volumes of 17.0–18.2 GW and net sales of US$4.90–US$5.20 billion, reinforcing visibility into its order book and manufacturing plans. Building on this earnings strength and reaffirmed...

Why Saia (SAIA) is on investors’ radar right now Saia (SAIA) has drawn fresh attention after a recent share price move, with the stock showing strong trailing returns over the past year and past 3 months. This performance has prompted closer scrutiny of its fundamentals. See our latest analysis for Saia. Despite a small 1-day share price decline, Saia’s 30-day share price return of 19.52% and 1-year total shareholder return of 68.91% point to momentum building on top of its longer term...

In recent weeks, Encompass Health Corporation reported higher first‑quarter 2026 sales of US$1,586.6 million and net income of US$194.5 million, raised its full‑year net operating revenue guidance, continued share repurchases under its long‑running buyback, opened a new 50‑bed rehabilitation hospital in Concordville, Pennsylvania, and declared a quarterly dividend of US$0.19 per share payable on July 15, 2026. Together, the earnings beat, guidance increase, capacity expansion and ongoing...

Merck (NYSE:MRK) faces an upcoming Gardasil vaccine safety trial scheduled for late July, focusing on product safety and potential liability claims. The company has also published new research on a large scale, enzyme enabled synthesis route for its oral PCSK9 inhibitor candidate. This synthesis work could help support development of what may become one of the first oral PCSK9 treatments for cholesterol management. Merck enters these developments with its stock at $112.3 and a return of...

There's been a notable change in appetite for SmartRent, Inc. ( NYSE:SMRT ) shares in the week since its quarterly...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

The latest earnings release from NCS Multistage Holdings, Inc. ( NASDAQ:NCSM ) disappointed investors. We did some...

Mettler-Toledo International (MTD) closed out FY 2025 with fourth quarter revenue of US$1,129.7 million and basic EPS of US$14.02, setting the tone for a year where trailing twelve month revenue reached US$4.0 billion and EPS came in at US$42.17. Over recent quarters the company has seen revenue move from US$954.5 million in Q3 2024 to US$1,129.7 million in Q4 2025, while quarterly EPS stepped from US$10.01 to US$14.02. This has left investors focused on how these trends flow through to...

SPS Commerce, Inc. reported past first-quarter 2026 results with revenue of US$192.12 million, up from US$181.55 million a year earlier, while net income eased to US$19.73 million and diluted EPS to US$0.53. Alongside completing a US$63.64 million share repurchase program, the company issued 2026 guidance pointing to further revenue growth and steady profitability, highlighting management’s confidence in its business model. Next, we’ll examine how SPS Commerce’s revenue growth outlook and...

If you are wondering whether Miami International Holdings at around US$49.77 is priced attractively or not, the key question is how that tag compares with what the business could reasonably be worth. Over shorter periods, the stock has been active, with returns of 7.1% over the last 7 days, 20.5% over the last 30 days and 14.0% year to date, which hints that expectations and perceived risk are shifting. Recent coverage has focused on Miami International Holdings as part of broader...

Investors may be wondering if Qorvo at around US$88.97 is still offering value, or if most of the upside has already been priced in. The stock has had a mixed run, with a 22.9% return over the last year, a 14.4% gain over the past month and a 5.6% decline over the last week. Over five years, the return sits at a 46.7% loss. Recent price moves sit against a backdrop of ongoing interest in semiconductor stocks generally, as investors reassess which companies could benefit most from demand for...

SES AI (NYSE:SES) has converted its South Korea facility to produce NDAA-compliant drone battery cells for defense customers. The company signed a multi-year, $20 million distribution agreement with ATG EPower for North American energy storage systems. SES AI is applying AI tools to optimize defense-focused battery products, expanding its use of the technology beyond R&D. SES AI, trading at about $0.921 per share, is shifting focus beyond long-cycle EV battery development toward products...

Dell Technologies (NYSE:DELL) has agreed to work with TotalEnergies and NVIDIA on Pangea 5, a next generation high performance supercomputer. The project focuses on large scale, AI driven computing infrastructure for energy, research, and advanced analytics use cases. Pangea 5 is designed with energy efficient architecture aimed at supporting complex industrial and scientific workloads. For readers tracking NYSE:DELL, this contract highlights the company’s role in supplying core...

If you are wondering whether Kraft Heinz is a bargain or a value trap at around US$23.66, this article breaks down what that price really implies for you. The stock has recently returned 4.4% over the last week and 2.1% over the last month, yet is still showing a 3.0% decline year to date and an 11.7% decline over the past year. Recent coverage has focused on Kraft Heinz as a mature packaged food giant that investors often look to for stability, which can attract attention when prices move...

Wondering whether agilon health’s recent action has left the stock looking expensive or still potentially mispriced? This article breaks down what the current price might be implying about its value. The stock last closed at US$60.66, with returns of 117.0% over 7 days, 265.6% over 30 days and 260.2% year to date. The 1 year and 3 year returns stand at negative 24.6% and negative 90.4% respectively. These sharp moves are drawing attention back to agilon health, especially as investors weigh...

Wondering if State Street stock still offers value after a strong run, or if most of the opportunity is already reflected in the price? This article focuses squarely on what you are paying for each dollar of fundamentals. At a recent close of US$148.78, the stock has returned 13.4% over the past month, 15.3% year to date, and 62.6% over the last year, with a 2.7% decline in the last week and longer term 3 year and 5 year returns of 142.5% and 103.6%. Recent headlines around large financial...

Why Astronics Stock Is Back in Focus Astronics (ATRO) is back on investors’ radar after a strong price trend, supported by positive earnings estimate revisions and favorable analyst opinions. The stock is now trading close to its 52-week high. See our latest analysis for Astronics. The recent momentum is clear, with a 7-day share price return of 9.17% and a year to date share price return of 37.70%. The 1-year total shareholder return is very large, and the 3-year total shareholder return is...

Tapestry, Inc. has already reported its fiscal third-quarter 2026 results, with net sales rising to US$1,920.6 million and net income reaching US$343.8 million, alongside affirming a US$0.40 per-share quarterly dividend and completing US$811.35 million of share repurchases under its current buyback. The quarter highlighted especially strong growth at Coach and in regions such as Greater China and Europe, even as Kate Spade weakened, underscoring how brand and geographic mix are shaping...

Bio-Techne Corporation reported its fiscal third-quarter 2026 results in early May, with net sales of US$311.42 million, a 2% year-over-year decline, while net income rose to US$51.05 million and diluted EPS from continuing operations increased to US$0.32. Alongside softer demand from emerging biotech customers and shipment timing issues that weighed on revenue, Bio-Techne’s profitability improved and the Board affirmed a quarterly cash dividend of US$0.08 per share, highlighting an ongoing...